-
2023-509296-16-00
4
2019-06-17
Moderate to severe hidradenitis suppurativa
-
2024-513915-28-00
3
2019-06-14
Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovar
-
2022-501970-20-01
5
2019-06-07
Cis-eligible Muscle-invasive bladder cancer.
-
2024-511316-25-00
3
2019-06-04
Urothelial carcinoma (UC)
-
2024-513470-22-00
9
2019-03-22
Progressive or refractory paediatric solid tumor
-
2022-502747-35-00
5
2019-02-18
Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ova
-
2022-502124-52-00
5
2018-12-18
Advanced epithelial ovarian cancer
-
2023-508253-98-00
5
2018-10-05
Gastric or gastroesophageal junction (GEJ) adenocarcinoma
-
2024-514179-17-00
5
2018-10-02
Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cerv
-
2024-514586-20-01
5
2018-05-02
Non small cell lung cancer
-
2023-504209-35-00
5
2018-04-04
Early-Stage Resectable Non-small cell lung cancer (NSCLC)
-
2024-516904-40-00
5
2018-03-27
Previously Untreated Diffuse large B-cell lymphoma (DLBCL)
-
2024-517439-39-00
7
2018-03-19
Metastatic castration-resistant prostate cancer.
-
2023-509595-42-00
5
2017-10-31
Gastric and gastroesophageal junction (GEJ) adenocarcinoma
-
2023-508757-75-00
5
2017-09-18
Stage IV Non-Small Cell Lung Cancer (NSCLC)
-
2024-515394-10-00
9
2016-04-26
Selected Advanced Solid Tumors
-
2023-505006-41-00
1
2015-05-11
QT interval prolongation
-
2023-504034-22-00
5
2014-12-18
Chronic Lymphocytic Leukemia (CLL)
-
2024-510784-36-00
9
2009-04-27
Children and Adolescents with Newly Diagnosed Chronic Phase CML or wit
-
2022-502087-21-00
7
Gastrointestinal Stromal Tumors (GIST)
-
2022-502622-40-00
1
Advanced Solid Tumors
-
2023-503807-27-00
4
Biliary tract carcinoma
-
2023-506240-16-00
9
Acute Myeloid Leukemia (AML)
-
2023-507344-36-01
4
Advanced or Metastatic Cancer
Merkel Cell Carcinoma (MCC)
Cutaneous Sq